Cargando…
A Bayesian comparative effectiveness trial in action: developing a platform for multisite study adaptive randomization
BACKGROUND: In the last few decades, the number of trials using Bayesian methods has grown rapidly. Publications prior to 1990 included only three clinical trials that used Bayesian methods, but that number quickly jumped to 19 in the 1990s and to 99 from 2000 to 2012. While this literature provides...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5006258/ https://www.ncbi.nlm.nih.gov/pubmed/27577191 http://dx.doi.org/10.1186/s13063-016-1544-5 |
_version_ | 1782451028915912704 |
---|---|
author | Brown, Alexandra R. Gajewski, Byron J. Aaronson, Lauren S. Mudaranthakam, Dinesh Pal Hunt, Suzanne L. Berry, Scott M. Quintana, Melanie Pasnoor, Mamatha Dimachkie, Mazen M. Jawdat, Omar Herbelin, Laura Barohn, Richard J. |
author_facet | Brown, Alexandra R. Gajewski, Byron J. Aaronson, Lauren S. Mudaranthakam, Dinesh Pal Hunt, Suzanne L. Berry, Scott M. Quintana, Melanie Pasnoor, Mamatha Dimachkie, Mazen M. Jawdat, Omar Herbelin, Laura Barohn, Richard J. |
author_sort | Brown, Alexandra R. |
collection | PubMed |
description | BACKGROUND: In the last few decades, the number of trials using Bayesian methods has grown rapidly. Publications prior to 1990 included only three clinical trials that used Bayesian methods, but that number quickly jumped to 19 in the 1990s and to 99 from 2000 to 2012. While this literature provides many examples of Bayesian Adaptive Designs (BAD), none of the papers that are available walks the reader through the detailed process of conducting a BAD. This paper fills that gap by describing the BAD process used for one comparative effectiveness trial (Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations) that can be generalized for use by others. A BAD was chosen with efficiency in mind. Response-adaptive randomization allows the potential for substantially smaller sample sizes, and can provide faster conclusions about which treatment or treatments are most effective. An Internet-based electronic data capture tool, which features a randomization module, facilitated data capture across study sites and an in-house computation software program was developed to implement the response-adaptive randomization. RESULTS: A process for adapting randomization with minimal interruption to study sites was developed. A new randomization table can be generated quickly and can be seamlessly integrated in the data capture tool with minimal interruption to study sites. CONCLUSION: This manuscript is the first to detail the technical process used to evaluate a multisite comparative effectiveness trial using adaptive randomization. An important opportunity for the application of Bayesian trials is in comparative effectiveness trials. The specific case study presented in this paper can be used as a model for conducting future clinical trials using a combination of statistical software and a web-based application. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02260388, registered on 6 October 2014 |
format | Online Article Text |
id | pubmed-5006258 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-50062582016-09-01 A Bayesian comparative effectiveness trial in action: developing a platform for multisite study adaptive randomization Brown, Alexandra R. Gajewski, Byron J. Aaronson, Lauren S. Mudaranthakam, Dinesh Pal Hunt, Suzanne L. Berry, Scott M. Quintana, Melanie Pasnoor, Mamatha Dimachkie, Mazen M. Jawdat, Omar Herbelin, Laura Barohn, Richard J. Trials Methodology BACKGROUND: In the last few decades, the number of trials using Bayesian methods has grown rapidly. Publications prior to 1990 included only three clinical trials that used Bayesian methods, but that number quickly jumped to 19 in the 1990s and to 99 from 2000 to 2012. While this literature provides many examples of Bayesian Adaptive Designs (BAD), none of the papers that are available walks the reader through the detailed process of conducting a BAD. This paper fills that gap by describing the BAD process used for one comparative effectiveness trial (Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations) that can be generalized for use by others. A BAD was chosen with efficiency in mind. Response-adaptive randomization allows the potential for substantially smaller sample sizes, and can provide faster conclusions about which treatment or treatments are most effective. An Internet-based electronic data capture tool, which features a randomization module, facilitated data capture across study sites and an in-house computation software program was developed to implement the response-adaptive randomization. RESULTS: A process for adapting randomization with minimal interruption to study sites was developed. A new randomization table can be generated quickly and can be seamlessly integrated in the data capture tool with minimal interruption to study sites. CONCLUSION: This manuscript is the first to detail the technical process used to evaluate a multisite comparative effectiveness trial using adaptive randomization. An important opportunity for the application of Bayesian trials is in comparative effectiveness trials. The specific case study presented in this paper can be used as a model for conducting future clinical trials using a combination of statistical software and a web-based application. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02260388, registered on 6 October 2014 BioMed Central 2016-08-31 /pmc/articles/PMC5006258/ /pubmed/27577191 http://dx.doi.org/10.1186/s13063-016-1544-5 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Methodology Brown, Alexandra R. Gajewski, Byron J. Aaronson, Lauren S. Mudaranthakam, Dinesh Pal Hunt, Suzanne L. Berry, Scott M. Quintana, Melanie Pasnoor, Mamatha Dimachkie, Mazen M. Jawdat, Omar Herbelin, Laura Barohn, Richard J. A Bayesian comparative effectiveness trial in action: developing a platform for multisite study adaptive randomization |
title | A Bayesian comparative effectiveness trial in action: developing a platform for multisite study adaptive randomization |
title_full | A Bayesian comparative effectiveness trial in action: developing a platform for multisite study adaptive randomization |
title_fullStr | A Bayesian comparative effectiveness trial in action: developing a platform for multisite study adaptive randomization |
title_full_unstemmed | A Bayesian comparative effectiveness trial in action: developing a platform for multisite study adaptive randomization |
title_short | A Bayesian comparative effectiveness trial in action: developing a platform for multisite study adaptive randomization |
title_sort | bayesian comparative effectiveness trial in action: developing a platform for multisite study adaptive randomization |
topic | Methodology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5006258/ https://www.ncbi.nlm.nih.gov/pubmed/27577191 http://dx.doi.org/10.1186/s13063-016-1544-5 |
work_keys_str_mv | AT brownalexandrar abayesiancomparativeeffectivenesstrialinactiondevelopingaplatformformultisitestudyadaptiverandomization AT gajewskibyronj abayesiancomparativeeffectivenesstrialinactiondevelopingaplatformformultisitestudyadaptiverandomization AT aaronsonlaurens abayesiancomparativeeffectivenesstrialinactiondevelopingaplatformformultisitestudyadaptiverandomization AT mudaranthakamdineshpal abayesiancomparativeeffectivenesstrialinactiondevelopingaplatformformultisitestudyadaptiverandomization AT huntsuzannel abayesiancomparativeeffectivenesstrialinactiondevelopingaplatformformultisitestudyadaptiverandomization AT berryscottm abayesiancomparativeeffectivenesstrialinactiondevelopingaplatformformultisitestudyadaptiverandomization AT quintanamelanie abayesiancomparativeeffectivenesstrialinactiondevelopingaplatformformultisitestudyadaptiverandomization AT pasnoormamatha abayesiancomparativeeffectivenesstrialinactiondevelopingaplatformformultisitestudyadaptiverandomization AT dimachkiemazenm abayesiancomparativeeffectivenesstrialinactiondevelopingaplatformformultisitestudyadaptiverandomization AT jawdatomar abayesiancomparativeeffectivenesstrialinactiondevelopingaplatformformultisitestudyadaptiverandomization AT herbelinlaura abayesiancomparativeeffectivenesstrialinactiondevelopingaplatformformultisitestudyadaptiverandomization AT barohnrichardj abayesiancomparativeeffectivenesstrialinactiondevelopingaplatformformultisitestudyadaptiverandomization AT brownalexandrar bayesiancomparativeeffectivenesstrialinactiondevelopingaplatformformultisitestudyadaptiverandomization AT gajewskibyronj bayesiancomparativeeffectivenesstrialinactiondevelopingaplatformformultisitestudyadaptiverandomization AT aaronsonlaurens bayesiancomparativeeffectivenesstrialinactiondevelopingaplatformformultisitestudyadaptiverandomization AT mudaranthakamdineshpal bayesiancomparativeeffectivenesstrialinactiondevelopingaplatformformultisitestudyadaptiverandomization AT huntsuzannel bayesiancomparativeeffectivenesstrialinactiondevelopingaplatformformultisitestudyadaptiverandomization AT berryscottm bayesiancomparativeeffectivenesstrialinactiondevelopingaplatformformultisitestudyadaptiverandomization AT quintanamelanie bayesiancomparativeeffectivenesstrialinactiondevelopingaplatformformultisitestudyadaptiverandomization AT pasnoormamatha bayesiancomparativeeffectivenesstrialinactiondevelopingaplatformformultisitestudyadaptiverandomization AT dimachkiemazenm bayesiancomparativeeffectivenesstrialinactiondevelopingaplatformformultisitestudyadaptiverandomization AT jawdatomar bayesiancomparativeeffectivenesstrialinactiondevelopingaplatformformultisitestudyadaptiverandomization AT herbelinlaura bayesiancomparativeeffectivenesstrialinactiondevelopingaplatformformultisitestudyadaptiverandomization AT barohnrichardj bayesiancomparativeeffectivenesstrialinactiondevelopingaplatformformultisitestudyadaptiverandomization |